1. 1.  科技部火炬计划， 
2. 2.  国家自然科学基金面上项目，项目负责人，82172010, “光还原-自组装”构建新型多功能蛋白质纳米探针用于脑胶质瘤的诊疗一体化研究，2022-2025.
   
3. 3.  国家自然科学基金面上项目，项目负责人，2024-2027.
4. 4.  东南大学启动基金，2020-
   
5. 5.  国家自然科学基金青年项目，项目负责人，31400810, 光控合成载siRNA的蛋白质纳米粒子治疗肿瘤的研究,，2014-2017。
   
6. 6.  第53届中国博士后基金，项目负责人，2013M531325，2013-2014。
   
7. 7.  日本学术振兴会（JSPS）特别研究员资助，2016-2018
   

近5年代表性文章

15.  Open-Source Throttling of CD8+ T Cells in Brain with Low-Intensity Focused Ultrasound-Guided Sequential Delivery of CXCL10, IL-2, and aPD-L1 for Glioblastoma Immunotherapy. Advanced Materials 2024, adma.202407235;(If=27.4，通讯作者)

14. Protein nanoparticles as drug delivery systems for cancer theranostics. Journal of Controlled Release  2024,371, 429-444;(If=10.8,通讯作者）

13.  Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions. Nature Nanotechnology 2020,15,605-614; (If=40.523，共同一作) 

12.   Recent Advances in Biomaterials-boosted Adoptive Cell Therapy. Chemical Society Reviews 2022, DOI: 10.1039/d1cs00786f; (IF=60.615，通讯作者) 

11.  Dual-sensitive Fab-encapsulated glucosylated nanocarrier for crossing the BBB and reducing amyloid beta plaques in Alzheimer’s disease mouse. ACS Nano 2020, 14，6729-6742; (If=18.027，第一作者)  

10.   Recruiting T cells towards brain for enhanced glioblastoma immunotherapeutic efficacy by co-delivery of cytokines and immune checkpoint antibodies with macrophage membrane-camouflaged nano vesicles. Advanced Materials 2023, adma.202209785; (If=32.086，通讯作者) 

9.   Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitorsand chemotherapeutic agents for glioblastoma therapy

Nature Communications, 2024, 15,1118（IF=17.694, 通讯作者).

8.     Micelles with ultralow critical micelle concentration as carriers for drug delivery, Nature Biomedical Engineering 2018, 2, 318-325；(If=29.234)  

7.    Conjugation of glucosylated polymer chains to checkpoint blockade antibodies augments their efficacy and specificity for glioblastoma. Nature Biomedical Engineering 2021,5,1274-1287; (If=29.234) 

6.   Nanomaterial-based blood-Brain-Barrier (BBB) crossing strategies. Biomaterials 2019, 224, 119491; (If=15.304，第一作者)  

5.   Targeted dual-siRNA delivery via non-viral polymeric vectors for idiopathic pulmonary fibrosis therapy. Advanced Materials 2021, 33，2007798; (If=32.086，通讯作者)   

4.  Co-delivery dual-siRNA of PTPN13 and NOX4 via myofibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy. Theranostics 2021,11,3244-3261; (If=11.6，通讯作者)

3.   Size-Changeable Nanoprobes for the Combined Radiotherapy and Photodynamic Therapy of Triple-Negative Breast Cancer. European Journal of Nuclear Medicine and Molecular Imaging 2022, doi.org/10.1007/s00259-022-05830-9；(IF=10.057，通讯作者)

2.  Photo-inducible protein-inorganic nanoparticle assembly for active targeted tumor theranostics. Nanoscale 2019,11，6136-6144; (IF=8.307，第一作者)

1.   Simple Protein Modification Using Zwitterionic Polymer to Mitigate the bioactivity Loss of Conjugated Insulin, Advanced Healthcare Materials 2017, 6, 1601428, (IF=11.092，第一作者)